Synthetic biologySynthetic biology involves designingdesigning, engineering, and building biological systems using standardized biological parts. Standardized biological parts include DNA fragments that code for proteins and DNA elements that regulate transcription. There are common techniques for identifying, isolating, storing and manipulating these biological parts. The generation of customized cells with fully synthetic genomes is another area of synthetic biology.
eGenesiseGenesis' stated goal is to make xenotransplantation a routine medical procedure. The company is a Cambridge, MA-basedMA-based startup that's using the gene-editing tool CRISPR to make pig organs viable for transplants into people.
eGenesis' stated goal is to make xenotransplantation a routine medical procedure. The company is a CambridgeCambridge, MA-based startup that's using the gene-editing tool CRISPR to make pig organs viable for transplants into people.
The company raised $38 million in March 2017 and is cofounded by Harvard geneticist George Church and Luhan YangLuhan Yang.. Their research is focusing on removing certain genes in pigs that could cause diseases or organ rejection in humans, making it possible for those pig organs to be transplanted. eGenesis announced in the journal Science that it had produced 37 piglets that had inactivated Porcine Endogenous Retrovirus, or PERV.
The company raised $38 million in March 2017 and is cofounded by Harvard geneticist George ChurchGeorge Church and Luhan Yang. Their research is focusing on removing certain genes in pigs that could cause diseases or organ rejection in humans, making it possible for those pig organs to be transplanted. eGenesis announced in the journal Science that it had produced 37 piglets that had inactivated Porcine Endogenous Retrovirus, or PERV.
The company raised $38 million in March 2017 and is cofounded by HarvardHarvard geneticist George Church and Luhan Yang. Their research is focusing on removing certain genes in pigs that could cause diseases or organ rejection in humans, making it possible for those pig organs to be transplanted. eGenesis announced in the journal Science that it had produced 37 piglets that had inactivated Porcine Endogenous Retrovirus, or PERV.
The company raised $38 million in March 20172017 and is cofounded by Harvard geneticist George Church and Luhan Yang. Their research is focusing on removing certain genes in pigs that could cause diseases or organ rejection in humans, making it possible for those pig organs to be transplanted. eGenesis announced in the journal Science that it had produced 37 piglets that had inactivated Porcine Endogenous Retrovirus, or PERV.
The company raised $38 million in MarchMarch 2017 and is cofounded by Harvard geneticist George Church and Luhan Yang. Their research is focusing on removing certain genes in pigs that could cause diseases or organ rejection in humans, making it possible for those pig organs to be transplanted. eGenesis announced in the journal Science that it had produced 37 piglets that had inactivated Porcine Endogenous Retrovirus, or PERV.
The company raised $38 million in March 2017 and is cofounded by Harvard geneticist George Church and Luhan Yang. Their research is focusing on removing certain genes in pigs that could cause diseases or organ rejection in humans, making it possible for those pig organs to be transplanted. eGenesis announced in the journal Science that it had produced 37 piglets that had inactivated Porcine Endogenous Retrovirus, or PERVPERV.
February 2, 2022
February 2, 2022
February 2, 2022
February 2, 2022
February 2, 2022
MiProbesMiProbes is developing a low cost, portable test for COVID-19 that would use a sample swab and give results in less than 1 hour. The company is screening human transcription factors (TFs) that bind COVID-19 viral peptides as an input to bind to DNA and trigger a reaction with their “bio-ink”. MiProbes will work with collaborators.
MiProbes is developing a low cost, portable test for COVID-19 that would use a sample swab and give results in less than 1 hour. The company is screening human transcription factors (TFs) that bind COVID-19 viral peptides as an input to bind to DNA and trigger a reaction with their “bio-ink”. MiProbes will work with collaborators.
Nuclear technology
Lynkeos Technology LtdThe primary focus of their work is the analysis of Intermediate-Level Nuclear Waste drums. The system identifies different materials, such as uranium and concrete, based on their density. Nuclear waste characterization is an ideal application for muography as imaging is not time-critical and there are no alternative technologies that provide similar capabilities. Given the quantity of nuclear waste stored globally, a growing need to be able to characterize and monitor the waste is required to improve safety and reduce storage costs.